Hormone medicine is moving fast.
Regulation, research and clinical guidance all shift faster in this field than most patients realize. We track it here, in plain language, including the parts that complicate our own position.
What’s changing.
FDA moves to remove boxed warning from menopausal hormone therapy
In November 2025 the FDA announced it is asking manufacturers to remove the broad “black box” warning from menopausal hormone therapy labels, citing updated evidence on benefits and risks. Talk with a clinician about whether HRT fits your health history.
Read →FDA updates testosterone labeling after TRAVERSE trial
In 2025 the FDA required class-wide labeling changes for testosterone products reflecting the TRAVERSE trial, which did not find increased major cardiovascular events, while keeping warnings about blood pressure increases. Monitoring with bloodwork remains important.
Read →Semaglutide shortage officially resolved
The FDA determined in February 2025 that the semaglutide (Wegovy/Ozempic) shortage is resolved, which affects how compounded versions may be made. Medical weight loss should be guided by a licensed clinician.
Read →Weight-loss medication and heart health: the SELECT trial
The SELECT trial (NEJM, 2023) found semaglutide reduced major cardiovascular events by about 20% in adults with overweight or obesity and existing heart disease, without diabetes.
Read →Understand this before you buy it.
Plain explanations written by our medical team. No pitch attached, no email gate. If you read all of it and decide you don’t need us, that’s a good outcome.
How to read your own hormone panel
What each marker measures, and why “in range” and “optimal” are different questions.
Four ways hormone clinics price, and what each really costs
Membership stacking, cheap intake with expensive panels, and cycle packages.
Low energy, weight gain and brain fog: what's worth testing
The symptoms most often dismissed, and which markers give you a real answer.
Perimenopause: what changes, when, and what can be done
The least understood and most under-treated part of women's hormone health.
Monitoring on TRT: the markers that matter over time
Hematocrit, estradiol, PSA and lipids. Why ongoing labs separate treatment from guesswork.
Recovery peptides: what the evidence actually supports
What's established, what's still being studied, and where regulation currently sits.
Does testosterone therapy cause blood clots?
One of the most common questions we get, and what the research says.
Can stress lower your testosterone?
The cortisol relationship, what's real, and what you can act on.
Fertility and TRT: what to know before you start
Why testosterone suppresses sperm production, and what the options are if fertility matters to you.
Understanding your testosterone results
What total testosterone measures, how SHBG and albumin change the picture, and why no single number tells the whole story.
Read everything. Then decide.
And if you’d rather start with your own numbers, the panel is $249 including the provider review.